iatroX logo
brainstormaskiatroXquizcpdknowledge centrehow it worksaboutblog
Knowledge Centre / Microscopic Polyangiitis (MPA)

Microscopic Polyangiitis (MPA)

Overview of small vessel vasculitis.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 August 2025
RheumatologyVasculitisNephrology

Clinical Guidelines

EULAR recommendations for the management of ANCA-associated vasculitis
National
NICE guideline [TA825]: Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis
National
NICE technology appraisal guidance [TA825]: Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis
National

Recent iatroX Q&As

  • What are the key clinical features that suggest a diagnosis of Microscopic Polyangiitis (MPA) in a patient presenting with systemic symptoms?Updated: 8/17/2025
  • What are the recommended first-line treatment options for a patient diagnosed with Microscopic Polyangiitis (MPA)?Updated: 8/17/2025
ask iatroX
privacy terms faq
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play